FDA grants EUA to Invivyd’s PEMGARDA for COVID-19 pre-exposure prophylaxis in immunocompromised individuals
Invivyd, Inc. (Nasdaq: IVVD), a pioneering biopharmaceutical company dedicated to safeguarding vulnerable populations from severe viral infectious diseases, has recently made headlines with the announcement ... Read More
WuXi Biologics and Toregem BioPharma to advance tooth regeneration treatment
WuXi Biologics ("WuXi Bio"), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced a strategic partnership with Toregem BioPharma, a biotech startup ... Read More
Novartis secures global rights to atopic dermatitis drug MOR106
In a strategic move to bolster its dermatology portfolio, Swiss pharmaceutical giant Novartis has entered into an agreement with MorphoSys and Galapagos to acquire exclusive ... Read More